- Home
- CDNA vs WEAV Comparison
CDNA vs WEAV Comparison
Compare CDNA & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- WEAV
- Stock Information
- Founded
- CDNA 1998
- WEAV 2011
- Country
- CDNA United States
- WEAV United States
- Employees
- CDNA N/A
- WEAV N/A
- Industry
- CDNA Medical Specialities
- WEAV EDP Services
- Sector
- CDNA Health Care
- WEAV Technology
- Exchange
- CDNA Nasdaq
- WEAV Nasdaq
- Market Cap
- CDNA 712.2M
- WEAV 571.3M
- IPO Year
- CDNA 2014
- WEAV 2021
- Fundamental
- Price
- CDNA $13.82
- WEAV $7.75
- Analyst Decision
- CDNA Buy
- WEAV Strong Buy
- Analyst Count
- CDNA 7
- WEAV 5
- Target Price
- CDNA $27.67
- WEAV $15.10
- AVG Volume (30 Days)
- CDNA 1.5M
- WEAV 1.1M
- Earning Date
- CDNA 11-03-2025
- WEAV 10-29-2025
- Dividend Yield
- CDNA N/A
- WEAV N/A
- EPS Growth
- CDNA N/A
- WEAV N/A
- EPS
- CDNA 1.00
- WEAV N/A
- Revenue
- CDNA $340,826,000.00
- WEAV $220,834,000.00
- Revenue This Year
- CDNA $13.02
- WEAV $18.93
- Revenue Next Year
- CDNA $12.85
- WEAV $15.86
- P/E Ratio
- CDNA $13.85
- WEAV N/A
- Revenue Growth
- CDNA 14.72
- WEAV 18.10
- 52 Week Low
- CDNA $10.96
- WEAV $6.75
- 52 Week High
- CDNA $32.97
- WEAV $17.63
- Technical
- Relative Strength Index (RSI)
- CDNA 54.96
- WEAV 50.65
- Support Level
- CDNA $12.37
- WEAV $7.40
- Resistance Level
- CDNA $14.20
- WEAV $7.77
- Average True Range (ATR)
- CDNA 0.73
- WEAV 0.26
- MACD
- CDNA 0.27
- WEAV 0.02
- Stochastic Oscillator
- CDNA 87.02
- WEAV 49.31
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.